Stockholm - Delayed Quote SEK

Generic Sweden AB (GENI.ST)

Compare
57.60
-0.40
(-0.69%)
At close: 5:29:56 PM GMT+2
Loading Chart for GENI.ST
  • Previous Close 58.00
  • Open 57.60
  • Bid 57.20 x --
  • Ask 57.60 x --
  • Day's Range 57.00 - 58.60
  • 52 Week Range 38.50 - 64.00
  • Volume 11,715
  • Avg. Volume 25,940
  • Market Cap (intraday) 708.019M
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) 25.95
  • EPS (TTM) 2.22
  • Earnings Date May 15, 2025
  • Forward Dividend & Yield 1.50 (2.59%)
  • Ex-Dividend Date May 16, 2024
  • 1y Target Est --

Generic Sweden AB, a technology company, provides messaging services for all applications. It also offers a platform for digital communication services. The company was incorporated in 1993 and is headquareted in Stockholm, Sweden.

www.generic.se

22

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GENI.ST

View More

Performance Overview: GENI.ST

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

GENI.ST
4.73%
OMX Stockholm 30 Index (^OMX)
3.95%

1-Year Return

GENI.ST
23.15%
OMX Stockholm 30 Index (^OMX)
5.11%

3-Year Return

GENI.ST
19.36%
OMX Stockholm 30 Index (^OMX)
12.53%

5-Year Return

GENI.ST
288.83%
OMX Stockholm 30 Index (^OMX)
69.81%

Compare To: GENI.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GENI.ST

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    712.94M

  • Enterprise Value

    672.32M

  • Trailing P/E

    26.13

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.04

  • Price/Book (mrq)

    12.91

  • Enterprise Value/Revenue

    3.81

  • Enterprise Value/EBITDA

    19.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.37%

  • Return on Assets (ttm)

    25.03%

  • Return on Equity (ttm)

    53.62%

  • Revenue (ttm)

    177.32M

  • Net Income Avi to Common (ttm)

    27.25M

  • Diluted EPS (ttm)

    2.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    40.62M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    15.41M

Research Analysis: GENI.ST

View More

Company Insights: GENI.ST

Research Reports: GENI.ST

View More

People Also Watch